Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander O König

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Digestion|August 18, 2020
Malignancies in Inflammatory Bowel DiseaseThomas Greuter, Stephan Vavricka, Alexander O König, et al.
Cancers|June 24, 2022
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor PrognosisSebastian C B Bremer, Gabi Bittner, Omar Elakad, et al.
The Journal of Biological Chemistry|June 2, 2011
Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acidShiv K Singh, Sandra Baumgart, Garima Singh, et al.
Scientific Reports|September 8, 2023
Predictors of lower exercise capacity in patients with cancerRuben Evertz, Christine Diehl, Katharina Gödde, et al.
ESC Heart Failure|September 30, 2022
Cardiovascular and metabolic determinants of quality of life in patients with cancerRuben Evertz, Katharina Gödde, Christine Diehl, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Digestion|August 18, 2020
Malignancies in Inflammatory Bowel DiseaseThomas Greuter, Stephan Vavricka, Alexander O König, et al.
Cancers|June 24, 2022
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor PrognosisSebastian C B Bremer, Gabi Bittner, Omar Elakad, et al.
The Journal of Biological Chemistry|June 2, 2011
Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acidShiv K Singh, Sandra Baumgart, Garima Singh, et al.
Scientific Reports|September 8, 2023
Predictors of lower exercise capacity in patients with cancerRuben Evertz, Christine Diehl, Katharina Gödde, et al.
ESC Heart Failure|September 30, 2022
Cardiovascular and metabolic determinants of quality of life in patients with cancerRuben Evertz, Katharina Gödde, Christine Diehl, et al.
Pageof 1